Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

Oncology

Volumn 64, Issue 1, 2003, Pages 28-35

  Cortes, Javier ^a   Rodriguez, Javier ^a   Aramendia, Jose Manuel ^a   Salgado, Esteban ^a   Gurpide, Alfonso ^a   Garcia Foncillas, Jesus ^a   Aristu, Jose Javier ^a   Claver, Angela ^a   Bosch, Ana ^a   Lopez Picazo, Jose Maria ^a   Martin Algarra, Salvador ^a   Brugarolas, Antonio ^b   Calvo, Emiliano ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b San Jaime Hospital   (Spain)

Author keywords

Brain metastases; Cisplatin; Gemcitabine; Non small cell lung cancer; Paclitaxel; Vinorelbine

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 18744393078     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066520     Document Type: Article

References (43)

1. Cancer Facts and Figures. American Cancer Society, 1996.
2. Shepherd FA: Future directions in the treatment of non-small cell lung cancer. Semin Oncol 1994;21:48-62.
3. MacGee EE: Surgical treatment of cerebral metastases from lung cancer: The effect of quality and duration of survival. J Neurosurg 1971;35:416-420.
4. Wen PY, Mclaren P, Loeffler JS: Metastatic brain cancer; in De Vita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, Ed 6. Philadelphia, Lippincott, 2001, pp 2655-2670.
5. Wen PY, Loeffler JS: Management of brain metastases. Rev Neurol 1992;148:477.
6. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid tumor patients: Natural history and results of treatment. Cancer 1981;48:384.
7. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
8. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427.
9. Lesser GJ: Chemotherapy of cerebral metastases from solid tumors. Neurosurg Clin North Am 1996;7:527-536.
10. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Non-small Cell Lung Cancer Collaborative Group [see comments]. BMJ 1995;311:899-909.
11. Grilli R, Oxman AD, Julian JA: Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough? J Clin Oncol 1993;11:1866-1872.
12. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E, Rapp E, Tumarello D, Williams J, Woods BL, Bernard JP: Polychemotherapy in advanced non small cell lung cancer: A meta-analysis [see comments]. Lancet 1993;342:19-21.
13. Cormier Y, Bergeron D, La Forge J, Lavandier M, Fournier M, Chenard J, Desmeules M: Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma. Cancer 1982;50:845-849.
14. Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J: Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer 1989;63:1271-1278.
15. Williams CJ, Woods R, Levi J, Page J: Chemotherapy for non-small cell lung cancer: A randomized trial of cisplatin/vindesine vs. no chemotherapy. Semin Oncol 1988;15:58-61.
16. Millward MJ, Bishop JF, Friedlander M, Levi JA, Goldstein D, Olver IN, Smith JG, Toner GC, Rischin D, Bell DR: Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol 1996;14:142-148.
17. Gatzemeier U, Heckmayr M, Neuhauss R, Schluter I, Pawel JV, Wagner H, Dreps A: Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer. Lung Cancer 1995;12(suppl 2):S101-S106.
18. Sekine I, Nishiwaki Y, Watanabe K, Yoneda S, Saijo N: Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer. Clin Cancer Res 1996;2:941-945.
19. Tester WJ, Jin PY, Reardon DH, Cohn JB, Cohen MH: Phase II study of patients with metastatic non small cell carcinoma of the lung treated with paclitaxel by 3-hour infusion. Cancer 1997;79:724-729.
20. Von Pawel J, Wagner H, Niederle N, Heider A, Koschel G, Hecker D, Hanske M: Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. Semin Oncol 1996;23:47-50.
21. Pirker R, Krajnik G, Zochbauer S, Malayeri R, Kneussl M, Huber H: Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC). Ann Oncol 1995;6:833-835.
22. Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van-Zandwijk N, Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T, Postmus PE: Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Lung Cancer Cooperative Group. J Clin Oncol 1998;16:2133-2141.
23. Bonomi P, Kim K, Kusler J, Johnson D: Cisplatin/etoposide vs. paclitaxel/cisplatin/G-CSF vs. paclitaxel/cisplatin in non-small-cell lung cancer. Oncology Huntington 1997;11:9-10.
24. Rowinsky EK, Gilbert MR, McGuire WP, Noe DA, Grochow LB, Forastiere AA, Ettinger DS, Lubejko BG, Clark B, Sartorius SE, Cornblath DR, Hendricks CB, Donehower RS: Sequences of taxol and cisplatin: A phase I and pharmacologic study. J Clin Oncol 1991;9:1692-1703.
25. Miller AB, Hoogstraten B, Staquet M: Reporting results of cancer treatment. Cancer 1981;147:207-214.
26. Kaplan E, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1959;53:457-481.
27. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
28. AJCC Cancer Staging Manual. Lippincott-Raven, 1997.
29. Frasci G, Panza N, Comella P, Nicolella GP, Natale M, Manzione L, Bilancia D, Cioffi R, Maiorino L, De Cataldis G, Belli M, Micillo E, Mascia V, Massidda B, Lorusso V, De Lena M, Carpagnano F, Contu A, Pusceddu G, Comella G: Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study. Southern Italy Cooperative Oncology Group. J Clin Oncol. 1999;17:2316-2325.
30. Sorensen JB, Stenbygaard LE, Dombernowsky P, Hansen HH: Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer. Ann Oncol 1999;10:1043-1049.
31. Lokich JJ, Anderson N, Bern M, Coco F, Dow E: The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: A phase I-II study of paclitaxel, cisplatin, and vinorelbine. Cancer 1999;85:499-503.
32. Rodriguez J, Cortes J, Calvo E, Azinovic I, Fernandez-Hildago O, Martinez-Monge R, Garzon C, de Irala J, Martinez-Aguillo M, Ramon y Cajal T, Brugarolas A: Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. Cancer 2000;89:2622-2629.
33. Comella P: Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer. Semin Oncol 2001;28(2 suppl 7):7-10.
34. Robinet G, Thomas P, Breton JL, Lena H, Gouva S, Dabouis G, Bennouna J, Souquet PJ, Balmes P, Thiberville L, Fournel P, Quoix E, Riou R, Rebattu P, Perol M, Paillotin D, Mornex F: Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Group Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. Ann Oncol 2001;1:59-67.
35. Cotto C, Berille J, Souquet PJ, Riou R, Croisile B, Turjman F, Giroux B, Brune J, Trillet-Lenoir V: A phase II trial of futemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. Eur J Cancer 1996;1:69-71.
36. Malacarne P, Santini A, Maestri A: Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide. Oncology 1996;53:210-213.
37. Lee JS, Pisters KM, Komaki R, Glisson BS, Khuri FR, Schea R, Fossella FV: Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: A preliminary report. Semin Oncol 1997;24(suppl 12):52-55.
38. Minotti V, Crino L, Meachi ML, Corgna E, Darwish S, Palladino MA, Betti M, Tonato M: Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 1998;20:93-98.
39. Franciosi V, Cocconi G, Michiara M, Di Costanzo F, Fosser V, Tonato M, Carlini P, Boni C, Di Sarra S: Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study. Cancer 1999;7:1599-1605.
40. Boogerd W, van der Sande JJ, van Zandwijk N: Teniposide sometimes effective in brain metastases from non-small cell lung cancer. J Neurooncol 1999;41:285-289.
41. Fujita A, Fukuoka S, Takabatake, Tagaki S, Sekine K: Combination chemotherapy of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. Oncology 2000;59:291-295.
42. Kelly K, Bunn PA: Is it time to reevaluate our approach to the treatmen of brain metastases in patients with non-small cell lung cancer? Lung Cancer 1998;20:85-91.
43. Postmus PE, Smit EF: Chemotherapy for brain metastases of lung cancer: A review. Ann Oncol 1999;10(7):753-759.